Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
Just nowReinstatement to Quotation
Just nowDiamond Drill Rig Locked in for Kanowna Gold Project
Just nowUpdate on alternative conflict process
Just nowReinstatement to Quotation
Just nowIBM Study: CEOs are Reshaping C-suite Roles for the AI Era
Lixte Biotechnology Holdings, Inc. logo

Lixte Biotechnology Holdings, Inc.

About

Lixte Biotechnology Holdings, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 20 2026
LIXTE Biotechnology Holdings (LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape
Apr 13 2026
LIXTE Biotechnology (LIXT) Reports Interim Ovarian Cancer Trial Results at SGO Conference
Apr 10 2026
Lixte Biotech Holdings (LIXT) Advances Precision Oncology Strategy With LB-100, Expands Clinical and Strategic Partnerships
Apr 2 2026
LIXTE Biotechnology Holdings (LIXT) Files 2025 Form 10-K, Highlights Transformational Year
Apr 1 2026
LIXTE Biotechnology (LIXT) Has the World's Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes
Case study
How Lixte Biotechnology Holdings, Inc. runs its investor program on 6ix — audience, formats, and program overview.

Community Chat

Ask AI

6ix6ixAIEvents